A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing

dc.contributor.authorMartí Puig, Eulàlia
dc.contributor.authorPantano, Lorena
dc.contributor.authorBañez-Coronel, Mónica
dc.contributor.authorLlorens Torres, Franc
dc.contributor.authorMiñones Moyano, Elena
dc.contributor.authorPorta, Sílvia
dc.contributor.authorSumoy, Lauro
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorEstivill, Xavier, 1955-
dc.date.accessioned2018-11-21T13:15:09Z
dc.date.available2018-11-21T13:15:09Z
dc.date.issued2010-06-30
dc.date.updated2018-11-21T13:15:09Z
dc.description.abstractHuntington disease (HD) is a neurodegenerative disorder that predominantly affects neurons of the forebrain. We have applied the Illumina massively parallel sequencing to deeply analyze the small RNA populations of two different forebrain areas, the frontal cortex (FC) and the striatum (ST) of healthy individuals and individuals with HD. More than 80% of the small-RNAs were annotated as microRNAs (miRNAs) in all samples. Deep sequencing revealed length and sequence heterogeneity (IsomiRs) for the vast majority of miRNAs. Around 80-90% of the miRNAs presented modifications in the 3'-terminus mainly in the form of trimming and/or as nucleotide addition variants, while the 5'-terminus of the miRNAs was specially protected from changes. Expression profiling showed strong miRNA and isomiR expression deregulation in HD, most being common to both FC and ST. The analysis of the upstream regulatory regions in co-regulated miRNAs suggests a role for RE1-Silencing Transcription Factor (REST) and P53 in miRNAs downregulation in HD. The putative targets of deregulated miRNAs and seed-region IsomiRs strongly suggest that their altered expression contributes to the aberrant gene expression in HD. Our results show that miRNA variability is a ubiquitous phenomenon in the adult human brain, which may influence gene expression in physiological and pathological conditions.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec677583
dc.identifier.issn0305-1048
dc.identifier.pmid20591823
dc.identifier.urihttps://hdl.handle.net/2445/126285
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/nar/gkq575
dc.relation.ispartofNucleic Acids Research, 2010, vol. 38, num. 20, p. 7219-7235
dc.relation.urihttps://doi.org/10.1093/nar/gkq575
dc.rightscc-by-nc (c) Martí et al., 2010
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationCorea de Huntington
dc.subject.classificationMalalties hereditàries
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherHuntington's chorea
dc.subject.otherGenetic diseases
dc.titleA myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
677583.pdf
Mida:
5.63 MB
Format:
Adobe Portable Document Format